Improvement in genetic evaluation of female fertility in dairy cattle using multiple-trait models including milk production traits

This study investigated the improvement in genetic evaluation of fertility traits by using production traits as secondary traits (MILK = 305-d milk yield, FAT = 305-d fat yield, and PROT = 305-d protein yield). Data including 471,742 records from first lactations of Denmark Holstein cows, covering the years of inseminations during first lactations from 1995 to 2004, were analyzed. Six fertility traits (i.e., interval in days from calving to first insemination, calving interval, days open, interval in days from first to last insemination, numbers of inseminations per conception, and nonreturn rate within 56 d after first service) were analyzed using single- and multiple-trait sire models including 1 or 3 production traits. Model stability was evaluated by correlation between EBV from 2 sub-data sets (DATA(A) and DATA(B)). Model predictive ability was assessed by the correlation between EBV from training data (DATA(A) or DATA(B)) and daughter performance (yield deviation, defined as average of daughter-records adjusted for nongenetic effects) from test data (DATA(B) or DATA(A)) in a cross-validation procedure, and correlation between EBV obtained from the whole data set (DATA(T)) and from a reduced data set (DATA(C1), which only contained the first crop daughters) for proven bulls. In addition, the superiority of the models was evaluated by expected reliability of EBV, calculated from the prediction error variance of EBV. Based on these criteria, the models combining milk production traits showed better model stability and predictive ability than single-trait models for all the fertility traits, except for nonreturn rate within 56 d after first service. The stability and predictive ability for the model including MILK or PROT were similar to the model including all 3 milk production traits and better than the model including FAT. In addition, it was found that single-trait models underestimated genetic trend of fertility traits. These results suggested that genetic evaluation of fertility traits would be improved using a multiple-trait model including MILK or PROT.

Association of human papillomavirus 7 with warts in toe webs

BACKGROUND

There have been no studies on the prevalence of types of human papillomavirus (HPV) in cutaneous warts that focus on warts in toe webs (WTW). There is no documented association between HPV 7 and WTW.

OBJECTIVES

To explore the clinical and histopathological features of WTW, and the distribution of HPV genotypes in patients with WTW.

METHODS

The study group consisted of 20 patients with WTW; 31 patients with typical verruca vulgaris (VV) were enrolled as the disease control group, and 53 patients with tinea pedis and 48 healthy volunteers were enrolled as the disease-negative control group. Tissue specimens were analysed for clinical and histological features and distribution of HPV genotypes. Polymerase chain reaction (PCR)-based direct sequencing, TA cloning and type-specific PCR (TS-PCR) were performed in the WTW and VV groups. Interdigital scale specimens from patients with tinea pedis and from healthy volunteers were analysed for HPV DNA by nested PCR and TS-PCR (HPV 7).

RESULTS

All the patients with WTW were male and nearly all were immunocompetent; their mean age was 41 +/- 10 years. The lesions presented mainly as soft, friable and vegetating clusters. HPV 7 was the predominant genotype in WTW with a frequency of 80% (16/20). Fourteen specimens were taken for histopathological examination. The most frequent histological results (seven out of 14) revealed characteristics of HPV 7 infections such as heavily stained cells containing medium-sized keratohyaline granules and a pronounced hyperkeratosis with parakeratosis. TA cloning showed that the sequence shared 90% or more homology with the HPV genotype in direct sequencing. No HPV 7 DNA was found in the scales taken from toe webs without warts.

CONCLUSIONS

This is the first study evaluating the prevalence of HPV types in WTW and the first report of the association between HPV 7 and specific subgroups of patients with warts.

Comparison between a sire model and an animal model for genetic evaluation of fertility traits in Danish Holstein population

Comparisons between a sire model, a sire-dam model, and an animal model were carried out to evaluate the ability of the models to predict breeding values of fertility traits, based on data including 471,742 records from the first lactation of Danish Holstein cows, covering insemination years from 1995 to 2004. The traits in the analysis were days from calving to first insemination, calving interval, days open, days from first to last insemination, number of inseminations per conception, and nonreturn rate within 56 d after first service. The correlations between sire estimated breeding value (EBV) from the animal model and the sire-dam model were close to 1 for all the traits, and those between the animal model and the sire model ranged from 0.95 to 0.97. Model ability to predict sire breeding value was assessed using 4 criteria: 1) the correlation between sire EBV from 2 data subsets (DATA(A) and DATA(B)); 2) the correlation between sire EBV from training data (DATA(A) or DATA(B)) and yield deviation from test data (DATA(B) or DATA(A)) in a cross-validation procedure; 3) the correlation between the EBV of proven bulls, obtained from the whole data set (DATA(T)) and from a reduced set of data (DATA(C1)) that contained only the first-crop daughters of sires; and 4) the reliability of sire EBV, calculated from the prediction error variance of EBV. All criteria used showed that the animal model was superior to the sire model for all the traits. The sire-dam model performed as well as the animal model and had a slightly smaller computational demand. Averaged over the 6 traits, the correlations between sire EBV from DATA(A) and DATA(B) were 0.61 (sire model) versus 0.64 (animal model), the correlations between EBV from DATA(T) and DATA(C1) for proven bulls were 0.59 versus 0.67, the correlations between EBV and yield deviation in the cross-validation were 0.21 versus 0.24, and the reliabilities of sire EBV were 0.42 versus 0.46. Model ability to predict cow breeding value was measured by the reliability of cow EBV, which increased from 0.21 using the sire model to 0.27 using the animal model. All the results suggest that the animal model, rather than the sire model, should be used for genetic evaluation of fertility traits.

Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro

Novel therapies are needed to address the vascular endothelial cell (EC) barrier disruption that occurs in inflammatory diseases such as acute lung injury (ALI). We previously demonstrated the potent barrier-enhancing effects of both sphingosine 1-phosphate (S1P) and the structurally similar compound FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] in inflammatory lung injury. In this study, we examined the therapeutic potential of several novel FTY720 analogs to reduce vascular leak. Similar to S1P and FTY720, the (R)- and (S)-enantiomers of FTY720 phosphonate and enephosphonate analogs produce sustained EC barrier enhancement in vitro, as seen by increases in transendothelial electrical resistance (TER). In contrast, the (R)- and (S)-enantiomers of FTY720-regioisomeric analogs disrupt EC barrier integrity in a dose-dependent manner. Barrier-enhancing FTY720 analogs demonstrate a wider protective concentration range in vitro (1-50 microM) and greater potency than either S1P or FTY720. In contrast to FTY720-induced EC barrier enhancement, S1P and the FTY720 analogs dramatically increase TER within minutes in association with cortical actin ring formation. Unlike S1P, these FTY720 analogs exhibit differential phosphorylation effects without altering the intracellular calcium level. Inhibitor studies indicate that barrier enhancement by these analogs involves signaling via G(i)-coupled receptors, tyrosine kinases, and lipid rafts. Consistent with these in vitro responses, the (S)-phosphonate analog of FTY720 significantly reduces multiple indices of alveolar and vascular permeability in a lipopolysaccharide-mediated murine model of ALI (without significant alterations in leukocyte counts). These results demonstrate the capacity for FTY720 analogs to significantly decrease pulmonary vascular leakage and inflammation in vitro and in vivo.